(3S)-5-(2,6-dichlorobenzoyl)oxy-3-[[(2S)-2-[[(2S)-3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]propanoyl]amino]-4-oxopentanoic acid

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 肽模拟物
• 英文名称: (3S)-5-(2,6-dichlorobenzoyl)oxy-3-[[(2S)-2-[[(2S)-3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]propanoyl]amino]-4-oxopentanoic acid
• 化学式: C₂₈H₃₁Cl₂N₃O₉
• 分子量: 624.5
• InChiKey: DFQKZFFVISYVDA-YFBXQHAESA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  42
• 可旋转键数：
  16
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  177
• 氢给体数：
  4
• 氢受体数：
  9

文献信息

• Combination Therapy with Inhibitors of HMGB and Caspase for the Treatment of Inflammatory Diseases
  申请人：Tracey Kevin J.

  公开号：US20100040607A1

  公开（公告）日：2010-02-18

  Compositions and methods are disclosed for treating a condition characterized by activation of an inflammatory cytokine cascade in a patient. The compositions comprise an agent that inhibits HMGB biological activity and a caspase inhibitor. The methods comprise treating a cell or a patient with sufficient amounts of the composition to inhibit the release of proinflammatory cytokine(s) and/or inhibit the inflammatory cytokine cascade.
• Treatment Of HIV-1 Infection And AIDS
  申请人：The J. David Gladstone Institutes

  公开号：US20150343011A1

  公开（公告）日：2015-12-03

  Provided herein are compositions and methods for the treatment of a patient having an HIV-1 infection and/or AIDS. More specifically this invention provides treatment of an HIV-1 infection and/or AIDS using small molecule compounds, such as inhibitors for the activation and/or activity of caspase-1. Inhibitors for the activation and/or activity of caspase-1 also prevent the cell death of CD4 T-cells in a population of CD4 T-cells comprising HIV-1 infected CD4 T-cells and uninfected CD4 T-cells. In addition, caspase-1 inhibitors inhibit inflammation, and pyroptosis.
• US6620782B1
  申请人：——

  公开号：US6620782B1

  公开（公告）日：2003-09-16
• US9352010B2
  申请人：——

  公开号：US9352010B2

  公开（公告）日：2016-05-31
• US9956260B1
  申请人：——

  公开号：US9956260B1

  公开（公告）日：2018-05-01